Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Other Products: In Vivo | Medtech Insight | HBW Insight | Pink Sheet | Generics Bulletin

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to Scrip? Start a free trial today!

Email
Share

Trinomab Biotech Co., Ltd.

http://

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Chinese Biotechs Raise $212m Through Major VC/PE Deals in November

Bookmark

01 Dec 2022
Analysis

By Dexter Yan

Leading the group were Trinomab Biotech, which develops antibodies for infectious diseases, and cell and gene developers BRL Medicine and XellSmart.

China Financing

Six Chinese Biotechs Bag $403m In Fresh Financing Rounds

Bookmark

27 Aug 2021
Analysis

By Dexter Yan

In immuno-oncology and beyond, Chinese investors are setting their sights on new targets in the biopharma arena.

China Financing

See All

Company Information

Industry
Biotechnology
- Large Molecule
  - Antibodies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Trinomab Biotech Co., Ltd.

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice